Phacoemulsification after trabeculectomy in uveitis associated with Vogt-Koyanagi-Harada disease: intermediate-term visual outcome, IOP control and trabeculectomy survival

Table 1 Demographics and ocular history^a

Variable	Study Group (N = 19)	Control Group (N = 19)	P-value
Age, years	29.21 (±9.1)	33.61 (±11.0)	0.19
Gender^b
Male (10)	2 (20.0%)	8 (80.0%)	0.09
Female (12)	7 (58.3%)	5 (41.7%)	0.09
Pre-Trabeculectomy:
LogMAR	0.68 (±0.5)	0.86 (±0.9)	0.10
Mean IOP before Trabeculectomy, mmHg	40.05 (±9.1)	39.16 (±8.4)	0.76
Mean number of antiglaucoma medications before Trabeculectomy	3.95 (±0.6)	3.74 (±0.7)	0.35
Concentration of MMC
0.02% (0.2 mg/ml) MMC	13	9	0.16
0.04% (0.4 mg/ml) MMC	6	10	0.16
Duration of MMC exposure (min)
0.02% (0.2 mg/ml) MMC	3.23 (±0.9)	3.00 (±0.7)	0.54
0.04% (0.4 mg/ml) MMC	3.33 (±0.5)	3.10 (±0.3)	0.28
Time to cataract surgery/study entry, months	33.21 (±33.3)	35.79 (±36.6)	0.82
Gonioscopy status
Open	14 (73.7%)	9 (47.4%)	0.09
Closed	5 (26.3%)	10 (52.6%)	0.09
Follow-up, months	45.75 (±36.4)	50.33 (±38.9)	0.71

^aData are presented as mean (±SD) and frequencies (%). Numbers are per eyes
^bNumbers are per patients
P-values were calculated using Student t-test, Mann-Whitney U test and Chi-Square test

ISSN: 1471-2415